ArticleNPJ dementia2025

A Phase IIa clinical trial to evaluate the effects of anti-retroviral therapy in Alzheimer's disease (ART-AD).

A Campbell Sullivan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.